Improving contraceptive decision support for individuals with chronic conditions – UROP Symposium

Improving contraceptive decision support for individuals with chronic conditions

Daniela Burgos

Research Mentor: Minji Kang
Mentor Department: Not Available, Not Available
Author(s): Daniela Burgos, Minji Kang, Justine Wu
Session: Session 1 (9:00 AM – 9:50 AM)
Presentation Type: Poster 37

Abstract

Background: Selecting a contraceptive method is a complex and personal process that becomes more complicated for individuals with chronic conditions; they must consider the potential bidirectional impact of contraception on their condition or medications. Literature also shows that this issue is amplified for Spanish-speaking patients because of limited culturally appropriate resources, ultimately contributing to lower care utilization rates and higher contraception nonuse rates compared to English-speaking patients. My Health, My Choice (Mi salud, mi decisión) (MHMC) is a novel web-based contraceptive decision support tool designed for patients with chronic conditions. The tool provides tailored contraceptive education in the context of a patient’s condition, medication, and personal characteristics in English and Spanish to support informed decision-making with their provider.

Objective: To assess the efficacy of My Health, My Choice on various contraception outcomes for English and Spanish-speaking patients with chronic conditions in primary care or obstetric care settings.

Methods: We will conduct a mixed-methods cluster randomized control trial (RCT), which compares patient outcomes between participants in the intervention arm (MHMC + usual care) and control arm (usual care). Quantitative surveys and qualitative interviews will be collected from an estimated 725 patients among 17 clinics in the United States. The primary outcome is contraceptive nonuse at 3 months, and secondary outcomes will measure contraceptive method safety, decisional conflict, and interpersonal quality of family planning. We will also analyze these outcomes by preferred language (i.e., Spanish vs. English).

Expected Results: We hypothesize that MHMC will be associated with greater contraceptive use at 3 months compared to usual care and mediated by improved decisional conflict and greater interpersonal quality of family planning. We also expect that the impact of MHMC on all patient outcomes will be greater for Spanish-speaking patients than for English-speaking patients.

lsa logoum logo